Status:
RECRUITING
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Samsung Electronics
Conditions:
Obstructive Sleep Apnea of Adult
Eligibility:
All Genders
22+ years
Brief Summary
The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
Detailed Description
A prospective cohort of 150 individuals 22 years or older with a prior diagnosis or with a high likelihood of having moderate to severe OSA, screened using STOP-Bang and Epworth Sleepiness Scale quest...
Eligibility Criteria
Inclusion
- 22 years of age or older
- High pre-test likelihood of moderate to severe obstructive sleep apnea (OSA) based on screening questionnaires (STOP-Bang and Epworth Sleepiness Scale); or prior diagnosis of moderate-severe OSA.
- Able to provide informed consent confirmation
Exclusion
- Severe and/or other acute medical illnesses as determined by the Investigator, in particular: Cardiac conditions such as Congestive Heart Failure (CHF), atrial fibrillation, Hx of Movement disorders: Parkinson's, Tremor, Lung conditions: Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, emphysema, pulmonary fibrosis, acute episode of flu, allergies, asthma.
- Active comorbid sleep disorders, such as severe insomnia, restless legs syndrome, Periodic Leg Movement During Sleep (PLMS), narcolepsy, idiopathic hypersomnia
- Severe and/or unstable psychiatric disorders such as mood, anxiety, or psychotic disorders
- Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk
- Inability to use a Samsung Galaxy device for sleep tracking
- Inability to have two nights in the Stanford sleep lab.
- Participants who are pregnant
- Tattoos or scars covering the forearm area of both hands
Key Trial Info
Start Date :
December 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06603441
Start Date
December 17 2024
End Date
February 1 2026
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305